Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer
Clinical trial NCT05694936 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05694936
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2026-01-21
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.